SCIDEV LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.37 AUD | -3.90% |
|
-1.33% | +42.31% |
| 05-02 | SciDev to Place Ravensthorpe Nickel Operation on Care, Maintenance; Shares Down 4% | MT |
| 04-18 | SciDev Posts AU$29 Million Revenue in Fiscal Q3 | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- The stock, which is currently worth 2024 to 0.61 times its sales, is clearly overvalued in comparison with peers.
- Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- For several months, analysts have been revising their EPS estimates roughly upwards.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Over the past four months, analysts' average price target has been revised upwards significantly.
Ratings chart - Surperformance
Sector: Environmental Services & Equipment
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +42.31% | 46.59M | - | ||
| +16.98% | 45.04B | C+ | ||
| +14.83% | 14.41B | C+ | ||
| +14.91% | 5.71B | C+ | ||
| +16.14% | 5.34B | B | ||
| 0.00% | 3.98B | B- | ||
| +17.20% | 2.28B | - | ||
| -16.18% | 2.03B | C+ | ||
| -4.86% | 1.55B | - | ||
| -2.47% | 1.45B | C+ |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
-
Price to Free Cash Flow
-
Yield
-
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- SDV Stock
- Ratings SciDev Limited
